Janus Henderson Group plc 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:09 pm Purchase | 2024-12-31 | 13G | Mereo BioPharma Group plc MREO | JANUS HENDERSON GROUP PLC JHG | 17,122,563 11.000% | 17,122,563 (New Position) | Filing |
| 2024-12-06 11:37 am Purchase | 2024-11-29 | 13G | Mereo BioPharma Group plc MREO | JANUS HENDERSON GROUP PLC JHG | 15,917,259 10.300% | 3,571,393 (+28.93%) | Filing |
| 2024-11-14 11:44 am Purchase | 2024-09-30 | 13G | Mereo BioPharma Group plc MREO | JANUS HENDERSON GROUP PLC JHG | 12,345,866 8.000% | 4,400,162 (+55.38%) | Filing |
| 2024-07-11 11:46 am Purchase | 2024-07-01 | 13G | Mereo BioPharma Group plc MREO | JANUS HENDERSON GROUP PLC JHG | 7,945,704 5.200% | 7,945,704 (New Position) | Filing |